Combination Therapy by Tissue-Specific Suicide Gene and Bevacizumab in Intramedullary Spinal Cord Tumor

PURPOSE: Malignant gliomas are aggressive spinal cord tumors. In this study, we hypothesized that combination therapy using an anti-angiogenic agent, bevacizumab, and hypoxia-inducible glioblastoma-specific suicide gene could reduce tumor growth. MATERIALS AND METHODS: In the present study, we evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Gwak, So-Jung, Che, Lihua, Yun, Yeomin, Lee, Minhyung, Ha, Yoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700877/
https://www.ncbi.nlm.nih.gov/pubmed/33251778
http://dx.doi.org/10.3349/ymj.2020.61.12.1042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700877/
https://www.ncbi.nlm.nih.gov/pubmed/33251778
http://dx.doi.org/10.3349/ymj.2020.61.12.1042

Ejemplares similares